The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.
about
The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The peroxisome proliferator-ac ...... acebo-controlled cohort study.
@en
The peroxisome proliferator-ac ...... acebo-controlled cohort study.
@nl
type
label
The peroxisome proliferator-ac ...... acebo-controlled cohort study.
@en
The peroxisome proliferator-ac ...... acebo-controlled cohort study.
@nl
prefLabel
The peroxisome proliferator-ac ...... acebo-controlled cohort study.
@en
The peroxisome proliferator-ac ...... acebo-controlled cohort study.
@nl
P2093
P2860
P1433
P1476
The peroxisome proliferator-ac ...... acebo-controlled cohort study.
@en
P2093
Adrian Shifren
Bryan Belikoff
David E Scherrer
Debra Kemp
Derek E Byers
Elizabeth Arentson
Frank J Brooks
Hideji Fujiwara
Howard J Huang
Jacquelyn T Engle
P2860
P304
P356
10.1371/JOURNAL.PONE.0191783
P407
P577
2018-02-07T00:00:00Z